New cancer drug enters human testing for Tough-to-Treat tumors
Disease control
Recruiting now
This study is testing a new drug called CLIO-8221 in people with advanced solid tumors that have spread or cannot be removed by surgery. The main goals are to find the safest and most effective dose and to see if the drug can shrink tumors. It is for patients who have already tri…
Phase: PHASE1, PHASE2 • Sponsor: Callio Therapeutics • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC